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This study compared the qualitative and quantitative 
differences of the melanosomal matrix proteins between 
the ellipsoidal-lamellar melanosomes of B16 melanoma 
and the spherical-granular melanosomes of Harding 
Passey (HP) melanoma by electron microscopy and SDS 
(sodium dodecyl sulfate)-PAGE (polyacrylamide gel elec-
trophoresis). The purity of the melanosomes at each step 
of the sample preparations was assayed by % distribu-
tion of cytoplasmic marker enzymes and proteins. Char-
acterization of the melanosomal matrix was carried out 
in material purified by the 2 steps of sucrose density 
gradient ultracentrifugation and membrane dissociation 
with BRIJ;35. Eighty-three percent of the matrix pro-
teins were solubilized from both B16 and HP by guani-
dine HCl (GH), which also caused marked ultrastructural 
changes in different ways. The inner matrix of HP com-
pletely disintegrated into tine grains whereas the matrix 
of B16 showed a great loss in electron density and was 
degraded, though its basic framework remained un-
changed. Under SDS-P AGE, the melanosomal matrix 
was dissociated into 14 polypeptide bands with respect 
to size and charge density, 10 of which (63-85% of total 
proteins solubilized by GH) were common to both B16 
and HP. A significant quantitative difference was noted 
in the relative amounts of these common proteins. The 
remaining 4 were unique in molecular weight to each 
form ofmelanosome though their relative amounts were 
low. It is suggested that these chemical differences, i.e., 
quantitative and qualitative, of the matrix proteins are 
responsible for the ultrastructural differentiation of mel-
anosomes. 
Among the various cellular and subcellular components, the 
key unit controlling the -morphogenesis of melanosome may be 
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the chemical nature and the mode of three dimensional assem, 
bly of (a) tyrosinase, (b) matrix proteins, (c) phospholipids, an~ 
(d) melanins. Our previous report [I] showed that Bl6 an~ 
Harding Passey (HP) mouse melanomas provide a good animal 
model for the study of melanosome morphogenesis, i.e., ellip, 
soidal-lamellar in Bl6 and spherical-granular in HP. We have 
shown that these 2 forms of melanosomes possess tyrosinase ' 
which is identical in molecular weight (mol wt), common in 
antigenicity, and similar in kinetic constant. It was suggeste~ 
that tyrosinase is not primarily involved in the morphological 
differentiation of melanosomes. 
Recently direct or indirect evidence for the presence of matr~ 
proteins other than tyrosinase within melanosomes has been 
accumulated. Earlier, Duchon et al [2] reported that the acid, 
hydrolyzed melanosomes of mouse melanomas and retinal pig, 
ment epithelium contain all the usual amino acids present in 
proteins and that there is not a great difference in their quan, 
titative compositions of amino acids. Hearing and Lutzner [3], 
Doezema [ 4], Klingler et al [5] and Hearing and Eppig (6] late!' 
attempted to partially solubilize melanosomes with hot urea m 
sodium dodecyl sulfate (SDS) and analyzed the solubilized, 
proteins by polyacrylamide gel electrophoresis (PAGE). These 
reports were, however, based primarily on one form of mela-
nosomes and little study has been carried out to correlate the 
matrix proteins with the morphological differentiation of mel-
anosomes. 
7(; 
The purpose of this study was to characterize the matrix 
proteins of Bl6 and HP melanosomes by electron microscopy 
and SDS-PAGE in the hope of better elucidating to what extent ' 
matrix proteins are related to the ultrastructural differentiation 
of melanosomes. 
MATERIALS AND METHODS 
Source and Purification. of Melanosomes 
Melanosomes were isolated from B16 and HP mouse melanomas by 
a sucrose density gradient ultracentrifugation (SDGU), as reported 
previously [1]. 
Purity of Melan.osomes . 
The purity of the melanosomal fraction was checked by electron 
microscopy and by percentage distribution of cytoplasmic marker en· 
zymes and proteins. For electron microscopy, the melanosomes were 
either peUeted or suspended in phosphate buffer (1 mM, pH 6.8). The 
melanosome suspension was dropped in formvar-coated grids, air-dried, 
and stained with 0.15% uranyl acetate. The melanosome pellet was 
prefixed with a mixture of 2.5% glutaraldehyde and 2.5% paraformal-
dehyde in cacodylate buffer (0.1 M, pH 7.2) for 2 hr and postfixed with 
2 % osmium tetroxide in cacodylate buffer (0.1 M, pH 7.2) for 2 hL The 
fixed pellet was dehydrated with ethanol solutions, mounted in epoxy 
resin, u.ltrasectioned, stained with lead citrate and uranyl acetate, and 
examined under a Hitachi HS-8 electron microscope. 
The purity of the melanosomal fraction was also examined by the 
enzymic activities of various cytoplasmic organelles. Acid phosphatase 
(Acid Pase) and glucose-6-phosphatase (G-6-Pase) were assayed by the 
methods of Gianetto and de Duve [7] and Swanson [8], respectively. 5'· 
nucleotidase (5'-AMPase) was determined by a modification of the 
method of Heppe! and Hilmoe [9). The reaction mixtw·e contained 0.1 
M Tris-HCl buffer (pH 8.5), 10 mM MgCh, 20mM 5'-AMP, and enzyme 
in a final volume of 1.0 rnl. The reaction was continued for 20 min at 
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TABLE I. Distribution of mar her proteins and enzymes of cytoplasmic organelle in melanosomal fractions before and after purification by 
SDGU" 
Harding Passey Melanosome BIG Melanosome 
Cytoplasmic Markers Crude homogenate After Ist SDGU" After lind SDGu+++ Crude homogenate After Ist SDGU 
After Ilnd 
SDGU+++ 
SA • %" SA % SA % SA % SA % SA % 
Thiamine pyrophosphataset 40.2 100 11.4 3.5 0.0 0.0 21.3 100 3.9 6.2 0.0 0.0 
Glucose-6-phosphataset 12.3 100 3.5 3.5 0.0 0.0 25.8 100 2.4 4.0 0.0 0.0 
Acid phosphataset 12.4 100 13.0 7.0 0.0 0.0 8.7 100 2.4 4.0 0.0 0.0 
5'-AMPase 2.9 100 0.8 1.8 0.0 0.0 6.5 100 0.0 0.0 0.0 0.0 
NADH-cytochrome CH re- 20.0 100 0.0 0.0 0.0 0.0 20.0 100 0.0 0.0 0.0 0.0 
ductase 
RNA tt 19.0 100 2.5 12.2 1.0 0.1 14.5 100 3.0 18.2 0.5 0.3 
DNAtt 42.5 100 0.0 0.0 0.0 0.0 94.0 100 10.0 9.4 0.0 0.0 
Tyrosinased 0.004 100 0.125 80.0 0.069 '6.7 0.002 100 0.18 75.0 0.016 4.8 
" SDGU:sucrose density gradient ultracentrifugation. 
b SA:specific activity. 
c %:% distribution of the cytoplasmic markers with that of crude homogenate. 
d Unit of tyrosinase (dopa-oxidase) / mg of protein. 
t n mole inorganic phosphatase/ min/ rug protein. 
:j: n mole paranitrophenol/min/ mg protein. 
t:j: n mole reduced cytochrome C/ min/ mg protein. 
tt p.g of DNA or RNA/mg protein. 
ttt Melanosomal fraction purified by one passage of SDGU was treated with BRIJ and then applied to the second passage of SDGU. 
30°C and stopped by adding 0.1 ml of 20% trichloroacetic acid. After 
cooling in ice and centrifugation, the inorganic phosphate liberated was 
determined. The blank value obtained by using 2' (3')-AMP instead of 
5'-AMPase substrate was subtracted from the value obtained above. 
Thiamine pyrophosphatase (TPPase) and NADH-cytochTOme C re-
ductase activities were assayed by the methods described by Yamazaki 
and Hayashi [10], and Mackler [11], respectively. Tyrosinase activity 
was measured using dihydroxylphenylalanine (dopa) as substrate by 
the previously reported method [1]. 
To rule out the nuclear components in the melanosome fraction, the 
amounts of DNA and RNA were also examined by the method of 
Burton [12] using diphenylamine for DNA and that of Schneider [13] 
with an orcinol reaction for RNA. 
Solubilization of Melanosomes 
Two extraction procedure steps were employed in solubilizing the 
melanosomal constituents. First, melanosomal proteins constituting the 
outer membrane and surface of the melanosomes were released by 0.1% 
BRIJ-35 (polyoxyethylene(23 mol) Iaury! ether) in sodium phosphate 
buffer (1 mM, pH 6.8). Second, the BRIJ-treated pellet was applied to 
another passage of SDGU and the leached melanosomes were then 
treated with 7 M guanidine HCI (GH) in sodium phosphate buffer (10 
mM, pH 8.0) to characterize the matrix proteins. BRIJ treatment was 
carried out with a T eflon-glass homogenizer (1 ,000 rpm, 3 min in the 
cold) , and GH treatment with a Polytron homogenizer (gage No. 5, 5 
min, at room temperature). The homogenate was centrifuged (105,000 
g 30 min) and the supernatant was collected. In several experin1ents, 
the melanosomes after one passage of SDGU were exposed to either 
0.5% SDS alone or combination of 0.5% SDS and 5% mercaptoethanol 
(ME) in Tris-HCl buffer (0.05 M, pH 8.0) . In addition, some of the GH 
pellets (in 2 experiments) were fUJ"ther treated with 8 M w·ea in Tris-
HCl buffer (0.05 M, pH 8.0) at 60°C for 5 days with a constant stirring. 
Polyacrylamide Gel Electrophoresis (PAGE) 
Disc-PAGE was made in either the slab or cylindrical gels with 0.1% 
SDS. A SDS-PAGE (7.5 or 10%) with cylindrical gels was performed 
by the method of Weber and Osborn [14) with or without a stacking 
gel. A slab ~DS-PAGE with gradient .gels of 7.5%, 10%, or 10-15% was 
carried out m the buffer system descnbed by Laemmh and Favre [15]. 
The samples were dialyzed against a sample buffer containing 0.1% 
SDS and 5% ME and boiled for 2 min before application. GH-solubili..zed 
material was, however, extensively dialyzed against 8 M w·ea before 
treatment with the sample buffer. Usually, 150 iJ.g protein of samples 
was applied to each tube or slot for fractionation of the protein-
subunits• of the melanosomal constituents. The protein pattern in the 
gels was stained with 0.1% Coomassie brilliant blue (CBB) R-250 
• The term "subunit" is used in this paper as a convenient expression 
for the polypeptide components released from the melanosomes by 
dissociating agents and does not 1·efer to the as yet unidentified biosyn-
thetic subunits of the melanosomes. 
overnight and destained with methanol-acetic acid solutions. Densito-
metric tracing of the CBB stained bands was carried out by a Toyo 
Digital Densitrol DHU-33C at 565 nm with a slit of0.5 X 5.0 mm. 
The subunit-mol wt of the proteins was determined by marker 
proteins of RNA polymerase (165,000, .8:155,000, a:39,000) , phosphor-
ylase A (94,000)-, bovine serum albumin (BSA) (68,000) , catalase 
(60,000) , the heavy chain of y-globulin (50,000), ovalbumin (43,000) and 
trypsin inhibitor (21,500). A mi..xtUJ·e of the ·marker proteins, approxi-
mately 5-10 ILg each, was electrophoresed in duplicate on each side of 
the gels, with their relative mobilities (Rx) being plotted as a function 
0f the logarithm of their respective mol wt. 
Protein Content 
Protein content was measmed by the Folin-Lowl'y method [16) after 
boiling of the melanosomal sample in 1 N NaOH for 30 min at 100oc 
and subtraction of the absorbancy of melanin from the experimental 
sample. BSA was used as a standard protein. 
RESULTS 
Purity of Melanosomal Fraction 
Table I shows the purity of the melanosomes after SDGU. 
After one passage of SDGU, the melanosomal fractions con-
tained some enzymic activities (3-6% of crude homogenates) of 
cytoplasmic organelle such as G-6-Pase, TPPase and Acid Pase 
in both B16 and HP. These fractions also possessed a small 
amount of DNA and RNA (9-18% of crude homogenates) . None 
of these activities related to mitochoncb-ia (NADH cytochrome 
C reductase) and cytoplasmic membrane (5' -AMPase) were 
found. The second passage of SDGU after BRIJ treatment 
produced purified melanosomes in which none of the activities 
of TPPase, G-6-Pase a nd Acid Pase were found. RNA and 
DNA were negligible, but a small amount of tyrosinase activity 
was found in both B16 and HP. 
Ultrastructure of Melanosomal Matrix after Chemical 
Treatment 
The ultrastructure of melanosomes after one SDGU pw-ifi-
cation has been shown previously [1]. Briefly Bl6 a nd HP 
melanosomes were composed of the melanized matrix with 
lamellar or granular patterns. The outer sw-face was associated 
with some proteinaceous materials. 
The pellets of Bl6 and HP after BRIJ treatment (Step I 
extractio.n) revealed the mela nosomes to be devoid of the outer 
membrane and exposed the inner core (Fig 1, A, B). There were 
no obvious ultrastructural changes in the matrices (core) ofB16 
and HP melanosomes except for some fragmentation and de-
crease in the electron opacity of the outer surface, indicating 
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FIG 1. Ultrastructural changes of the melanosomal matrix after chemica l treatment. A, Bl6 melanosomes after polyoxyethylene lame\ ether 
(BRIJ) treatment (X 14,500). B, HP melanosomes after BRIJ treatment (X 14,000). C, Bl6 melanosomes a fte r guanidine HCl (GH) treatment 
(X 15,000). D, HP melanosomes after GH treatment (Xl3,000) . I 
that BRIJ affected primarily the surface and cortex of the 
melanosomes. After GH treatment (Step II extraction) , there 
was a marked ul trastructural change in the matrices ofBl6 and 
· HP melanosomes. The core of the B16 melanosomes was de-
graded in such a way that it had become less electron dense, 
partially fragmented, and fuzzy (Fig 1, C). The HP melanosomes 
were degraded to such an extent that the granular materials of 
the inner matrix were almost completely dissociated (Fig 1, D). 
Solubility of Melanosomal Matrix Proteins after Chemical 
Treatment 
Table II shows the yield of the solubilized matrix proteins 
and the amount of the unsolubilized proteins in each sample 
preparation step. Both Bl6 and HP melanosomes revealed the 
solubility of melanosomal proteins to be basically similaT. BRIJ 
treatment solubilized 5-7% of the proteins from the melano-
somes after the first SDGU. The BRIJ pellet (87-91% of the 
original untreated melanosomal fraction) was further applied to 
the second passage of SDGU. By means of this passage, about 
74% of the proteins in the BRIJ pellet of B16 and HP was 
recovered. Subsequent treatment with GH (Step II extraction) 
released about 83% of the remaining matrix proteins from both 
B16 and HP melanosomes. The amount of the sobubilized 
proteins corresponded to 53-56% of the total proteins present 
in the original untreated melanosomal fractions . The remaining 
of unsolubilized matrix proteins were only 8-10% of the original 
untreated materials. In 2 experiments, th e GH pellet was further 
exposed to 8 M urea, which, further, solubilized 6.6% of the GH 
pellet in Bl6 and 8.2% in HP. 
SDS-PAGE Profiles of Matrix Proteins in Melanosomes 
The melanosomal proteins ofBl6 and HP were compared by 
slab gels of SDS-PAGE in Fig 2 and 3. Figure 2, concerned with 
the 10-16% gradient gels, shows the melanosomal protein 
released by different solvents from B16 after one passage of 
SDGU. The GH, SDS and SDS plus ME released 5 well-
resolved bands, arbitrarily labeled I-V, the positions and den -
ities of which were basically similar. Besides these 5 major 
bands, there were a number of minor bands that were not only 
weaker in staining intensity, but also were affected in number 
by different solvents. The bands ofBRIJ-treated materials wel'e 
less numerous and less stained with CBB than those of G H and 
SDS, though they had been treated with BRIJ under the same 
conditions. 
Differences in the polypeptide bands in the melanosomal 
matrix proteins between B16 and HP are compared in Fig 3 of 
standru·d SDS-PAGE. There were about 14 visible bands (see 
the arrows in gels #4 and #7) in the materials solubilized by 
GH after BRIJ and the second passage of SDGU. Most of the 
polypeptide bands in B16 and HP migrated to identical po ·-
tions, ranging in size from 160,000 to 20,000 daltons. Among the 
14 visible bands, 10 were common to both Bl6 and HP. Four to 
5 bands were major in HP and B16. Again, there was no 
significant difference in the number and position of the poly-
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TABLE II. Solubilization and distribution of melanosomal proteins in each step of samp le prep aration 
Sample preparation" Hardi ng Passey Melanosome B16 Melanosome 
Step Type of treatment 
1 First SDG U" 
2 BRIJ treatment'' 
Supernatant 
Pellet 
3 Second SDG U'' 
4 GH treatment" 
Supernatant 
Pellet 
P rotein concen-
tJ·ation (mg/ml) 
6.6 
0.7 
5.7 
4.2 
5.7 
1.2 
" Sample star ted from 10 gm of tumor. 
"Sucrose density gradient ultracentrifugation. 
" 0.1% BRIJ -35 
"7 M guanidine HCI 
Total protein Distribu tion (%) (mg) 
213 100 
14 6.6 
185 86.9 
136 63.8 
(100)'' 
113 53.1 
(83.1)'' 
16 7.5 
(11.8)'' 
Protein concen- Total protein DistTibution (%) tration (mg/ ml) (mg) 
6.0 144 100 
0.7 8 5.6 
3.0 131 91.0 
3.8 96 66.7 
(100)" 
4.0 80 55.6 
(83.3)" 
1.3 15 12.4 
(15.6)" 
• Distribu tion of melanosomal proteins after the second passage of S DG U. 
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FIG 2. Comparison of the solubi lity of B16 melanosomes afte r t he 
first passage of SDGU by treatment with polyoxyethylene laurel ether 
(BRIJ ), gua:1idine HCl (GH) , sodium dodecyl sulfate (SDS), and SDS 
plus mercaptoethanol (ME) . The electrophoresis was carried ou t by 
SDS-PAGE wi th 10-16% gradients. 1, 7 M GH (120 J.Lg); 2, 7 M GH plus 
BRIJ (150 J.Lg); 3, 4, 0.1% BRIJ (80 J.Lg); 5, 7 M GH (150 J.Lg); 6, 0.5% SDS 
(150 J.!g); and 7, 0.5% SDS plus 5% ME. Mol wt is calibra ted along the 
left corner of the gel (X w-a daltons). The materials of BRIJ , SDS and 
SDS plus ME were treated under the same conditions as those of GH. 
N umbers (I- V) are arbi trarily labeled for the major components. 
peptide bands released by GH (gel # 8), SDS (# 9) and SDS 
plus ME (gel #10) . A striking difference between Bl6 a nd HP 
melanosomes was noted in the s taining intensi ty of m ajor 
common prot e ins to CBB, e.g., the # 3 polypeptide bands (mol 
wt:33,000 daltons), indicating that there is a significan t differ-
en ce in t h e r elative a bunda nce of common subunit-proteins 
between Bl6 and HP m ela nosomes. 
The qualita tive and quanti ta tive differe nces between Bl6 
a nd HP in th e poly peptide bands of the melanosomal m atrix 
pr o teins are furth er shown in Table III, wher e the s ize (mol wt) 
and the relative abundan ce (percenta ge s tain to CBB) of poly-
p eptide bands in #4 and #7 gels of Fig 3, i. e., the GH solubilized 
m at erials after BRIJ treatment and 2 passages of SDGU, were 
estimated by a densitometric tracing. Among 14 subunit-pro-
165-
155 
94 
68-
60 
5 
21--
1 2 
I (!) 
• J J 
a: a: 
CD CD 
3 4 
HP 
J 
I a: 
0 CD 
5 6 
I (!) 
+ J 
a: I 
CD (!) 
7 8 
816 
UJ 
:2 
Cf) CJ5 
0 0 
Cf) Cf) 
9 10 
FIG 3. Comparison of !:H6 and HP melanosomes extracted by poly-
oxyethylene laurel ether (BRIJ) , guanidine HCl (GH), sodium dodecyl 
sulfate (SDS) and SDS plus mercaptoethanol (ME). The electropho-
resis was carried out by SDS-PAGE in 10% gels. Gels from 1 to 2 
conta in the marker proteins (see Materials and Methods). The mol wt 
is shown along left corner of the gel (x w - :l daltons). Gels from 3 to 5 
are the materials of HP melanosome ; gel 3, 0. 1% BRIJ ( t.ep I) of the 
first sucrose density gradient ultracentrifugation (SDGU) fraction; gel 
4, 7 M GH (Step II) to the BRIJ pellet after the second passage of 
SDG U; and 5, 7 M G H of the first SDG U fraction. Gels from 6 to 10 are 
the materials of B16 melanosomes; gel 6, 0.1% BRIJ (Step I) of the first. 
SDG U fraction; gel 7, 7 M G H (Step II) to the BRIJ pellet after the 
second pa sage of SDGU; gel 8, 7 M GH of the first SDGU fractiOn; gel 
9, 0.5% SDS; and gel 10, 0.5% SDS plus 5% ME of the first SDG U 
fraction. A rrows [1- 14} along the right corner of the gels indicate ~h e 
ru·bitrarily labeled number of polypeptide bands in concentratiOn high 
enough to be detected. 
teins, the ma trix proteins common to both Bl6 a nd HP were 
10, wi t h about 63% of t hem in HP a nd 85% in Bl6 aga inst total 
matrix proteins. Four of them wer e the m ajor protein-subuni ts 
of B16 and HP. These proteins sh owed a marked qua nt itative 
difference. Again, one of the common proteins r evealed a sig-
nificant difference in relative a bundance, i.e. , #3 subunit -pro-
te ins (mol wt:33,000 daltons) comprised 14.4% in B16 but only 
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TABLE III. Mol wt and relative abundance (% stain to CBB) of the 
matrix proteins between B16 and HP melanosomes 
Harding Passey Bl6 
No. of 
bands Mol wt (XlO' ) Distribu- Mol wt (Xl04 ) Distribu-tion (%) tion (%) 
1 2.4 7.7 2.4 6.5 
2 2.8" 6.7 2.9 2.7 
3 -3~3- 1.8 3-:-3- 14.4 
4 4.1 14.81' 4.1 15.4 
5 4.4 3.I 4.4 10.9 
6 4.9 11.7 5.3 14.0 
7 5-:-3 m 5.9 4]! 
8 5.4 10.6 -6~4 3.8 
9 -6~8 4:7 -6~8 7.8 
10 7.5 4.8 7.7 2.8 
11 -8~3 3.6 -8-:3 3.9 
12 8.9 1.7 8.9 2.2 
13 9.4 4.5 9.4 2.2 
14 15.8 1.0 15.8 1.0 
Total protein 91.5% Total protein 92.4% 
Common/to- 63.1% Common/ to- 84.7% 
tal protein tal protein 
"---:Unique band. 
b 
-: Major band. 
1.8% in HP melanosomes. Furthermore, there were 4 species of 
subunit-proteins that were different with respect to mol wt 
between B16 (#2, 7, 8, 10) and HP (#2, 6, 8, 10). 
DISCUSSION 
This study characterized the qualitative and quantitative 
differences of the matrix proteins between ultrastructurally 
different melanosomes of B16 and HP melanomas. 
Our study with cytoplasmic marker enzymes indicated that 
the melanosomal fractions purified by one passage of SDGU 
were still associated with some cytoplasmic components related 
to the Golgi-lysosome system as well as to nuclear components. 
The presence of these components in the first SDGU fraction 
may be related to recent electron microscopic findings indicat-
ing that the outer membrane ofmelanosomes is often connected 
to either a specialized part of the Golgi-endoplasmic reticulum-
lysosome (GERL) system [17] or to an agranular portion of the 
rough endoplasmic reticulum and nuclear envelope [18,19]. 
Before characterization of the matrix proteins, BRIJ-treated 
melanosomes were processed through the second SDGU, which 
resulted in a complete loss of membranous components under 
electron microscopy. Enzymic activities of the Golgi-lysosome-
. endoplasmic system as well as of DNA and RNA components 
were negligible. However, the melanosomal fraction after the 
second passage of SDGU, i.e., the melanosomes purified by 2 
passages of SDGU after BRIJ treatment, contained a small 
amount (5-7%) oftyrosinase activity, indicating that the melan-
osomal matrix is also associated with active tyrosinase, though 
most of it is present in the BRIJ treated material. 
In both B16 and HP melanosomes, the GH treatment re-
leased at least 83% of the matrix proteins. Our previous electron 
microscopic study indicated that follicular melanosomes, which 
are ellipsoidal in outer shape and highly melanized in the 
matrix, were hardly degraded even by acid-hydrolysis under 
reflux [20]. In this study of Bl6 and HP, we found that there is 
a marked ultrastructural change of the melanosomal matrix by 
means of GH treatment. The inner matrix of HP completely 
disintegrated into fine grains whereas the matrix of B16 showed 
a great loss in electron density and appeared "moth-eaten," 
though its basic framework remained unchanged. This ultra-
structural difference in the matrix may indicate that the extent 
of melanosome degradation by chemical treatment differs de-
pending on the chemical compositions and mode of three di-
mensional assembly of melanin, matrix proteins, and, probably 
phospholipids. In addition, it may be suggested that a number 
of structural components present in the matrix of B16 melano-
somes are missing or minimally present in that of HP. 
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Several studies have been reported in which attempts to 
electrophoretically characterize the melanosomal proteins from 
various tissues were made, but there have been discrepancies 
with regard to the number and specificity of their subunit-
proteins. Klingler et al [5] reported that the melanosomes from 
human and chick eyes, and human and mouse (S91) melano-
mas, which are of the ellipsoidal-lamellar type of B16 in our 
system, were resolved into more than 25 polypeptide bands 
with respect to mol wt and charge density when solubilized by 
Triton X-100 and when electrophoresed by SDS-PAGE of the 
Tris-glycine buffer system. Hearing and Eppig [6], using the 
same technique of SDS-PAGE as that of Klingler et al [5], 
reported that SDS-solubilized melanosomes of mouse and chick 
eyes, mouse melanoma (S91) and frog skin of Xenopus Laevis 
oocyte, were resolved into 6-10 polypeptide bands and that the 
material extracted after sequential treatment with either urea 1 
or SDS revealed a single band with a mol wt of 50,000 or 70,000 
daltons. They assumed the protein resolved by the second 
extract to be an "internal melanin granule protein," inasmuch 1 
as the first extract with SDS disrupted and solubilized only the 
limiting membrane of melanosomes. In contrast, the SDS- 1 
PAGE study of Doezema [4] by the method of Laemmli [15] 
showed (a) that the ellipsoidal-lamellar melanosomes of chick 
eye, mouse black hair and B16 melanoma were resolved into at 
least 20 polypeptide bands when solubilized by 2% SDS and 5% 
ME (100°C, 2 min), (b) that these bands were similar in number 1 
and mol wt distribution, and (c) that 6 of these bands were of 
major quantitative importance ranging in mol wt from 40,000 
to 60,000 daltons. 
In our SDS-PAGE with 2 different buffer systems, the results 
were very similar among the materials solubilized by GH, SDS, I 
and SDS plus ME. In B16 melanosomes, 14 polypeptide bands 
were resolved in concentrations high enough to be traced, with 
5 of them being major subunit-proteins, comprising approxi-
mately 63% of the total solubilized materials. In HP melano-
somes, we also found 14 polypeptide bands, 4 of which were of 
major quantitative importance. Among the 14 bands of both 
B16 and HP, 10 were common in mol wt (about 63-85% of total 
proteins). However, significant differences between B16 and 1 
HP melanosomes were noted in (a) the relative amount (% 
distribution) of major common proteins, e.g., 33,000 dalton-
protein which comprised 14.4% of B16 and 1.8% of HP, and in 
(b) several minor proteins, the sizes of which were unique to I 
each form of melansome. The fact that the major difference of 
the melanosomal matrix proteins between B16 and HP is the 
relative amount of the common proteins may well explain the 
results of our previous study [21], i.e., that the synthesis of the 1 
ellipsoidal-lamellar melanosomes and the spherical-granular 
melanosomes is interchangeable in a single melanocyte during 
normal hair growth. A further study using a technique such as 
two dimensional PAGE may, however, be required to obtain 
the exact values for the number, mol wt, and charge density of 
subunit-proteins in B16 and HP melanosomes. 
The authors wish to express many thanks for Dr. V.J. Hearing for 
his critical review of the manuscript, to Miss M. Kiyota for her technical 
assistance in carrying the study and Miss T . Niikawa for her typing the 
manuscript. 
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